APC and colorectal cancer: For example, although most colorectal cancers exhibit adenomatous polyposis coli (APC) mutations affecting the WNT signaling pathway (Huyghe et al. 2019), β-catenin, a downstream biomolecule of APC, has emerged as an effective therapeutic target (Zhang and Wang 2020).